Polyvalent complexes for vaccine development

Biomaterials

Volumn 34, Issue 18, 2013, Pages 4480-4492

  Wang, Leyi ^a   Huang, Pengwei ^a   Fang, Hao ^a   Xia, Ming ^a   Zhong, Weiming ^a   McNeal, Monica M ^a,b   Jiang, Xi ^a,b   Tan, Ming ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Influenza virus vaccine; Multivalent vaccine; Norovirus vaccine; Polyvalent complex; Rotavirus vaccine; Vaccine platform

Indexed keywords

COMPLEX COMPONENTS; COMPLEX FORMATIONS; GLUTATHIONE-S-TRANSFERASE; INFLUENZA VIRUS; NOROVIRUS; POLYVALENT COMPLEX; ROTAVIRUSES; VACCINE DEVELOPMENT;

DIMERS; EPITOPES; MAMMALS; PROTEINS; VACCINES; VIRUSES;

COMPLEX NETWORKS;

ANTIGEN; DIMER; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; ROTAVIRUS VACCINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; DIMERIZATION; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS; MOUSE; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; ROTAVIRUS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; FEMALE; HUMANS; IMMUNE SERA; LIGANDS; MICE; MICE, INBRED BALB C; NOROVIRUS; ORTHOMYXOVIRIDAE; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; ROTAVIRUS; T-LYMPHOCYTES; VACCINATION; VIRAL PROTEINS; VIRAL VACCINES; VIRUS DISEASES;

NOROVIRUS; ORTHOMYXOVIRIDAE; ROTAVIRUS;

EID: 84875592440     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.041     Document Type: Article

References (34)

1. Atmar R.L., Bernstein D.I., Harro C.D., Al-Ibrahim M.S., Chen W.H., Ferreira J., et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011, 365:2178-2187.
2. Herbst-Kralovetz M., Mason H.S., Chen Q. Norwalk virus-like particles as vaccines. Expert Rev Vaccines 2010, 9:299-307.
3. Tan M., Fang P., Chachiyo T., Xia M., Huang P., Fang Z., et al. Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
4. Tan M., Huang P., Xia M., Fang P.A., Zhong W., McNeal M., et al. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011, 85:753-764.
5. Tan M., Jiang X. The formation of P particle increased immunogenicity of norovirus P protein. Immunology 2012, 136:28-29.
6. Tan M., Jiang X. Norovirus P particle, a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine 2012, 7:1-9.
7. Tan M., Xia M., Huang P., Wang L., Zhong W., McNeal M., et al. Norovirus P particle as a platform for antigen presentation. Procedia in Vaccinology 2011, 4:19-26.
8. Xia M., Tan M., Wei C., Zhong W., Wang L., McNeal M., et al. A candidate dual vaccine against influenza and noroviruses. Vaccine 2011, 29:7670-7677.
9. Manayani D.J., Thomas D., Dryden K.A., Reddy V., Siladi M.E., Marlett J.M., et al. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 2007, 3:e142.
10. Nassal M., Skamel C., Kratz P.A., Wallich R., Stehle T., Simon M.M. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 2005, 35:655-665.
11. Johnson J., Lin T., Lomonossoff G. Presentation of heterologous peptides on plant viruses: genetics, structure, and function. Annu Rev Phytopathol 1997, 35:67-86.
12. Lin T., Porta C., Lomonossoff G., Johnson J.E. Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution. Fold Des 1996, 1:179-187.
13. Lin T., Johnson J.E. Structures of picorna-like plant viruses: implications and applications. Adv Virus Res 2003, 62:167-239.
14. Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res;161:47-58.
15. Li S., Tang X., Seetharaman J., Yang C., Gu Y., Zhang J., et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009, 5:e1000537.
16. Tan M., Meller J., Jiang X. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol 2006, 80:7322-7331.
17. Tan M., Hegde R.S., Jiang X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol 2004, 78:6233-6242.
18. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 2005, 79:14017-14030.
19. Tan M., Zhong W., Song D., Thornton S., Jiang X. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol 2004, 74:641-649.
20. Tan M., Fang P.A., Xia M., Chachiyo T., Jiang W., Jiang X. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 2011, 410:345-352.
21. + T cell epitopes. J Virol 2010, 84:8530-8538.
22. Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow A.L., et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 2003, 188:19-31.
23. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 2005, 79:6714-6722.
24. Fritz-Wolf K., Becker A., Rahlfs S., Harwaldt P., Schirmer R.H., Kabsch W., et al. X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A 2003, 100:13821-13826.
25. Bu W., Mamedova A., Tan M., Xia M., Jiang X., Hegde R.S. Structural basis for the receptor binding specificity of Norwalk virus. J Virol 2008, 82:5340-5347.
26. Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 2007, 81:5949-5957.
27. Chen Y., Tan M., Xia M., Hao N., Zhang X.C., Huang P., et al. Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog 2011, 7:e1002152.
28. Tan M., Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 2005, 13:285-293.
29. Tan M., Jiang X. Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog 2010, 6:e1000983.
30. Tan M., Jiang X. Virus-host interaction and celluar receptors of caliciviruses. Caliciruses 2010, 111-130. Caister Academic Press, Norwich. G. Hansman (Ed.).
31. Tan M., Jiang X. Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol 2011, 19:382-388.
32. Boon D., Mahar J.E., Abente E.J., Kirkwood C.D., Purcell R.H., Kapikian A.Z., et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 2011, 85:8656-8666.
33. Bull R.A., Eden J.S., Rawlinson W.D., White P.A. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 2010, 6:e1000831.
34. Huang P., Morrow A.L., Jiang X. The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition. Glycoconj J 2009, 26:1085-1096.